eNauka - pregled
Pregled prema Projekat Yuhan Corporation
Prikaz rezultata 1 do 1 od 1
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2022 | A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829) | Cho, BC; ...; Zaric, Bojan   | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |